AVANOS MEDICAL INC (AVNS) Stock Fundamental Analysis
USA • New York Stock Exchange • NYSE:AVNS • US05350V1061
13.42 USD
-0.05 (-0.37%)
At close: Feb 3, 2026
13.54 USD
+0.12 (+0.89%)
Pre-Market: 2/4/2026, 7:08:24 AM
Taking everything into account, AVNS scores 4 out of 10 in our fundamental rating. AVNS was compared to 186 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of AVNS get a neutral evaluation. Nothing too spectacular is happening here. AVNS has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
- In the past year AVNS was profitable.
- In the past year AVNS had a positive cash flow from operations.
- In multiple years AVNS reported negative net income over the last 5 years.
- AVNS had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- AVNS's Return On Assets of -43.92% is on the low side compared to the rest of the industry. AVNS is outperformed by 63.98% of its industry peers.
- AVNS's Return On Equity of -60.27% is in line compared to the rest of the industry. AVNS outperforms 46.77% of its industry peers.
- AVNS has a Return On Invested Capital of 2.68%. This is in the better half of the industry: AVNS outperforms 69.35% of its industry peers.
- AVNS had an Average Return On Invested Capital over the past 3 years of 2.58%. This is significantly below the industry average of 8.80%.
- The last Return On Invested Capital (2.68%) for AVNS is above the 3 year average (2.58%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -43.92% | ||
| ROE | -60.27% | ||
| ROIC | 2.68% |
ROA(3y)-11.6%
ROA(5y)-7.22%
ROE(3y)-16.14%
ROE(5y)-10.03%
ROIC(3y)2.58%
ROIC(5y)N/A
1.3 Margins
- AVNS has a better Operating Margin (4.46%) than 69.35% of its industry peers.
- AVNS's Operating Margin has improved in the last couple of years.
- The Gross Margin of AVNS (52.28%) is comparable to the rest of the industry.
- AVNS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.46% | ||
| PM (TTM) | N/A | ||
| GM | 52.28% |
OM growth 3Y42.57%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.25%
GM growth 5Y-0.78%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AVNS is destroying value.
- Compared to 1 year ago, AVNS has less shares outstanding
- AVNS has less shares outstanding than it did 5 years ago.
- Compared to 1 year ago, AVNS has a worse debt to assets ratio.
2.2 Solvency
- AVNS has an Altman-Z score of 1.25. This is a bad value and indicates that AVNS is not financially healthy and even has some risk of bankruptcy.
- AVNS has a Altman-Z score of 1.25. This is comparable to the rest of the industry: AVNS outperforms 53.76% of its industry peers.
- AVNS has a debt to FCF ratio of 1.38. This is a very positive value and a sign of high solvency as it would only need 1.38 years to pay back of all of its debts.
- AVNS has a Debt to FCF ratio of 1.38. This is amongst the best in the industry. AVNS outperforms 89.25% of its industry peers.
- AVNS has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
- Looking at the Debt to Equity ratio, with a value of 0.12, AVNS is in the better half of the industry, outperforming 63.98% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | 1.38 | ||
| Altman-Z | 1.25 |
ROIC/WACC0.26
WACC10.27%
2.3 Liquidity
- A Current Ratio of 2.38 indicates that AVNS has no problem at all paying its short term obligations.
- AVNS's Current ratio of 2.38 is in line compared to the rest of the industry. AVNS outperforms 46.77% of its industry peers.
- A Quick Ratio of 1.36 indicates that AVNS should not have too much problems paying its short term obligations.
- With a Quick ratio value of 1.36, AVNS is not doing good in the industry: 61.29% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.38 | ||
| Quick Ratio | 1.36 |
3. Growth
3.1 Past
- AVNS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.76%.
- AVNS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.32% yearly.
- AVNS shows a small growth in Revenue. In the last year, the Revenue has grown by 2.70%.
- Measured over the past years, AVNS shows a decrease in Revenue. The Revenue has been decreasing by -0.28% on average per year.
EPS 1Y (TTM)-7.76%
EPS 3Y3.09%
EPS 5Y3.32%
EPS Q2Q%-38.89%
Revenue 1Y (TTM)2.7%
Revenue growth 3Y-2.61%
Revenue growth 5Y-0.28%
Sales Q2Q%4.34%
3.2 Future
- AVNS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.00% yearly.
- AVNS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.56% yearly.
EPS Next Y-27.14%
EPS Next 2Y-12.3%
EPS Next 3Y5%
EPS Next 5YN/A
Revenue Next Year1.39%
Revenue Next 2Y1.77%
Revenue Next 3Y1.56%
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 12.54, which indicates a correct valuation of AVNS.
- AVNS's Price/Earnings ratio is rather cheap when compared to the industry. AVNS is cheaper than 92.47% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 28.18, AVNS is valued rather cheaply.
- AVNS is valuated correctly with a Price/Forward Earnings ratio of 13.85.
- Based on the Price/Forward Earnings ratio, AVNS is valued cheaply inside the industry as 90.32% of the companies are valued more expensively.
- AVNS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.51.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.54 | ||
| Fwd PE | 13.85 |
4.2 Price Multiples
- 93.01% of the companies in the same industry are more expensive than AVNS, based on the Enterprise Value to EBITDA ratio.
- AVNS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AVNS is cheaper than 98.39% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.34 | ||
| EV/EBITDA | 9.14 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)3.77
EPS Next 2Y-12.3%
EPS Next 3Y5%
5. Dividend
5.1 Amount
- No dividends for AVNS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
13.42
-0.05 (-0.37%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)02-24 2026-02-24/bmo
Inst Owners96.89%
Inst Owner Change-0.3%
Ins Owners2.95%
Ins Owner Change0.25%
Market Cap622.96M
Revenue(TTM)699.90M
Net Income(TTM)-468.90M
Analysts43.33
Price TargetN/A
Short Float %7.23%
Short Ratio5.78
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)45.42%
Min EPS beat(2)11.11%
Max EPS beat(2)79.74%
EPS beat(4)4
Avg EPS beat(4)33.85%
Min EPS beat(4)2.94%
Max EPS beat(4)79.74%
EPS beat(8)4
Avg EPS beat(8)13.31%
EPS beat(12)7
Avg EPS beat(12)15.99%
EPS beat(16)10
Avg EPS beat(16)13.31%
Revenue beat(2)2
Avg Revenue beat(2)4.82%
Min Revenue beat(2)3.67%
Max Revenue beat(2)5.97%
Revenue beat(4)3
Avg Revenue beat(4)2.62%
Min Revenue beat(4)-0.66%
Max Revenue beat(4)5.97%
Revenue beat(8)3
Avg Revenue beat(8)0.51%
Revenue beat(12)3
Avg Revenue beat(12)-1.11%
Revenue beat(16)3
Avg Revenue beat(16)-4.54%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)13.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.37%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.81%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.54 | ||
| Fwd PE | 13.85 | ||
| P/S | 0.89 | ||
| P/FCF | 8.34 | ||
| P/OCF | 5.98 | ||
| P/B | 0.8 | ||
| P/tB | 2.38 | ||
| EV/EBITDA | 9.14 |
EPS(TTM)1.07
EY7.97%
EPS(NY)0.97
Fwd EY7.22%
FCF(TTM)1.61
FCFY11.99%
OCF(TTM)2.24
OCFY16.73%
SpS15.08
BVpS16.76
TBVpS5.64
PEG (NY)N/A
PEG (5Y)3.77
Graham Number20.09
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -43.92% | ||
| ROE | -60.27% | ||
| ROCE | 3.39% | ||
| ROIC | 2.68% | ||
| ROICexc | 2.9% | ||
| ROICexgc | 7.4% | ||
| OM | 4.46% | ||
| PM (TTM) | N/A | ||
| GM | 52.28% | ||
| FCFM | 10.67% |
ROA(3y)-11.6%
ROA(5y)-7.22%
ROE(3y)-16.14%
ROE(5y)-10.03%
ROIC(3y)2.58%
ROIC(5y)N/A
ROICexc(3y)2.84%
ROICexc(5y)N/A
ROICexgc(3y)9.32%
ROICexgc(5y)N/A
ROCE(3y)3.26%
ROCE(5y)N/A
ROICexgc growth 3Y51.11%
ROICexgc growth 5YN/A
ROICexc growth 3Y59.93%
ROICexc growth 5YN/A
OM growth 3Y42.57%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.25%
GM growth 5Y-0.78%
F-Score6
Asset Turnover0.66
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | 1.38 | ||
| Debt/EBITDA | 1.3 | ||
| Cap/Depr | 72.84% | ||
| Cap/Sales | 4.21% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 145.33% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.38 | ||
| Quick Ratio | 1.36 | ||
| Altman-Z | 1.25 |
F-Score6
WACC10.27%
ROIC/WACC0.26
Cap/Depr(3y)39.4%
Cap/Depr(5y)44.02%
Cap/Sales(3y)2.53%
Cap/Sales(5y)2.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.76%
EPS 3Y3.09%
EPS 5Y3.32%
EPS Q2Q%-38.89%
EPS Next Y-27.14%
EPS Next 2Y-12.3%
EPS Next 3Y5%
EPS Next 5YN/A
Revenue 1Y (TTM)2.7%
Revenue growth 3Y-2.61%
Revenue growth 5Y-0.28%
Sales Q2Q%4.34%
Revenue Next Year1.39%
Revenue Next 2Y1.77%
Revenue Next 3Y1.56%
Revenue Next 5YN/A
EBIT growth 1Y-18.96%
EBIT growth 3Y38.85%
EBIT growth 5YN/A
EBIT Next Year51.47%
EBIT Next 3Y22.03%
EBIT Next 5YN/A
FCF growth 1Y104.1%
FCF growth 3Y7.73%
FCF growth 5YN/A
OCF growth 1Y95.13%
OCF growth 3Y4.87%
OCF growth 5YN/A
AVANOS MEDICAL INC / AVNS FAQ
Can you provide the ChartMill fundamental rating for AVANOS MEDICAL INC?
ChartMill assigns a fundamental rating of 4 / 10 to AVNS.
What is the valuation status for AVNS stock?
ChartMill assigns a valuation rating of 6 / 10 to AVANOS MEDICAL INC (AVNS). This can be considered as Fairly Valued.
Can you provide the profitability details for AVANOS MEDICAL INC?
AVANOS MEDICAL INC (AVNS) has a profitability rating of 4 / 10.
Can you provide the expected EPS growth for AVNS stock?
The Earnings per Share (EPS) of AVANOS MEDICAL INC (AVNS) is expected to decline by -27.14% in the next year.